retatrutide phase 2 trial results Delivers Significant Hemoglobin A1C Reduction, Weight Loss in 3 Type Diabetes retatrutide phase 2 obesity trial

While the concentration of active peptides in shampoo formulations is typically lower than in dedicated serums, daily use provides consistent exposure and can complement other interventions

Sjstrm L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, et al

The researchers then calculated what the relative infant dose would be if semaglutide were present at the detection limit, the worst-case scenario

In the secondary analysis measuring progression to exudative AMD at 10 years compared with OWLD use, GLP-1 use (RR, 0.70) and no weight loss med use (RR, 0.52) were associated with a lower risk of progression to exudative AMD

Generic and biosimilar semaglutide: what's actually in the pipeline As of April 2026, the FDA has received zero Abbreviated New Drug Applications (ANDAs) for generic semaglutide